SEC 13F Intelligence

Telemetry Investments, L.L.C. / ALXN

Telemetry Investments, L.L.C.’s Alexion Pharmaceuticals Inc Position

Does Telemetry Investments, L.L.C. own Alexion Pharmaceuticals Inc (ALXN)? Not currently — the last reported position was 13.0K shares worth $2M in Q2 2021; the fund’s latest 13F (Q4 2022) no longer reports it.

Position Value
$2M
Q2 2021
Shares
13.0K
% of Portfolio
+3.28%
Quarters Held
3
position exited

Position History ALXN

Reported value by quarter
Q2 ’20: $224,000Q2 ’20Q1 ’21: $1MQ1 ’21Q2 ’21: $2MQ2 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q2 202113.0K$2M+3.28%
Q1 20218.1K$1M+1.40%
Q2 20202.0K$224,000+0.61%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Telemetry Investments, L.L.C.’s full portfolio or all institutional holders of ALXN.